2.3100
20-9月-24 15:54:34
15 分の遅延
株式
0.0000
0.00%
本日の幅
2.2500 - 2.4400
ISIN
N/A
ソース
NASDAQ
TFF Pharmaceuticals Partners with Emory University and BARDA to Develop a Dry Powder Inhaled mRNA-based Treatment for Influenza and COVID
11 9 2024 07:00:00 提供 Nasdaq GlobeNewswire
TFF Pharmaceuticals Announces Positive Preclinical Data from Bivalent Universal Influenza Vaccine Candidates Manufactured by TFF Following Intranasal Immunization
10 9 2024 07:00:00 提供 Nasdaq GlobeNewswire
TFF Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference
03 9 2024 08:00:00 提供 Nasdaq GlobeNewswire